PRODUCT TYPES – Page 14

Stability failure during stability pull: containment CAPA and effectiveness checks

The initial identification of a stability failure during stability pull typically arises from various symptoms observed on the production floor or within laboratory settings. Key signals may include:Click to read…

Finished product packaging leakage complaint after method transfer to a new QC lab: FDA-compliant investigation flow and batch disposition decision tree

Identifying the symptoms associated with packaging leakage is the first step in a robust investigation. Symptoms may manifest in various ways, including:Click to read the full article.

Occupational exposure limit breach during stability pull: risk assessment for patient safety

Recognizing the symptoms of an OEL breach during stability pulls is critical for timely intervention. Key indicators may include:Click to read the full article.

Finished product fill weight / volume variability after equipment calibration drift found: FDA-compliant investigation flow and batch disposition decision tree

Identifying symptoms of fill weight or volume variability begins with monitoring production output. Common signals include:Click to read the full article.

Assay drift during stability pull: FDA/EMA investigation expectations

Detection of assay drift during stability pulls often starts with subtle signals that can escalate into a significant quality concern. Recognizing these symptoms early is paramount for effective investigation and…

Finished product blend uniformity failure during recall risk assessment: manufacturing vs lab root cause mapping and required evidence

Identifying symptoms of a blend uniformity failure is the first critical step in any deviation investigation. Symptoms can manifest in various ways, including:Click to read the full article.

Cross-contamination risk during shared facility campaign: containment CAPA and effectiveness checks

Recognizing the symptoms of cross-contamination is crucial for timely response. Symptoms may manifest in several ways:Click to read the full article.

Finished product disintegration failure during complaint trending review: how to build a deviation package that passes an inspection deep-dive

Identifying symptoms associated with finished product disintegration failure is crucial for initiating an effective investigation. Common signals may include:Click to read the full article.

Assay drift during shared facility campaign: containment CAPA and effectiveness checks

The first step in addressing assay drift is identifying observable symptoms or signals during manufacturing processes or laboratory testing. Symptoms may appear as:Click to read the full article.

Finished product nitrosamine risk assessment gap after method transfer to a new QC lab: risk assessment for patient impact and field alert / recall triggers

Identifying symptoms or signals is the first step in the investigation process. Common indicators of a nitrosamine risk assessment gap post-method transfer may include:Click to read the full article.

Potency OOS during stability pull: risk assessment for patient safety

Identifying the symptoms associated with a potency OOS result is crucial to initiating an effective investigation. Symptoms typically observed might include:Click to read the full article.

Finished product viscosity drift during recall risk assessment: manufacturing vs lab root cause mapping and required evidence

Identifying symptoms or signals associated with viscosity drift is paramount. These signals may originate from various points in the manufacturing process or the laboratory setting. Key symptoms include:Click to read…